MacroGenics, Inc.
MGNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.04 | -0.00 | 0.03 |
| FCF Yield | -28.82% | -62.44% | -59.30% | -19.18% |
| EV / EBITDA | 2.87 | -1.59 | 0.72 | -4.67 |
| Quality | ||||
| ROIC | 8.05% | -17.43% | -24.43% | -25.60% |
| Gross Margin | 81.63% | 59.96% | 59.07% | 69.04% |
| Cash Conversion Ratio | -1.79 | 1.30 | 1.14 | 2.49 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.32% | 2.43% | -2.67% | -0.70% |
| Free Cash Flow Growth | 35.82% | -0.59% | -21.50% | -165.51% |
| Safety | ||||
| Net Debt / EBITDA | -1.96 | 0.69 | 2.76 | 11.68 |
| Interest Coverage | 5.58 | -45.83 | -468.40 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.53 | 0.96 | 0.57 | 0.00 |
| Cash Conversion Cycle | 104.44 | 97.38 | 118.74 | -60.31 |